Hark-Mo Seong

Title: Hark-Mo Seong: Innovator in Blood Coagulation Research

Introduction

Hark-Mo Seong is a notable inventor based in Choongchongbuk-do, South Korea. He has made significant contributions to the field of blood coagulation research. His innovative work has led to the development of a unique method for determining the enzymatic activity of blood coagulation factor XIII.

Latest Patents

Hark-Mo Seong holds a patent for a method titled "Method of determining the enzymatic activity of the blood coagulation factor XIII using purified fibrin monomer as a substrate." This invention relates to a method that utilizes purified fibrin monomer as a substrate to assess the enzymatic activity of blood coagulation factor XIII. The method involves detecting the degree of cross-linking of fibrin monomer formed by the enzyme, with the fibrin monomer free of blood coagulation factor XIII obtained through washing with citric acid solution. This innovative approach can effectively validate other enzymatic assay methods for blood coagulation factor XIII and aid in characterizing this important factor.

Career Highlights

Hark-Mo Seong is associated with Korea Greencross Corporation, where he continues to contribute to advancements in medical research and technology. His work has garnered attention for its potential applications in clinical settings.

Collaborations

He has collaborated with notable colleagues, including Hee-Chul Kim and Jae-Wook Huh, to further enhance the research and development of blood coagulation methods.

Conclusion

Hark-Mo Seong's innovative contributions to blood coagulation research exemplify the impact of dedicated inventors in the medical field. His patented method represents a significant advancement in understanding and measuring enzymatic activity, which can lead to improved clinical practices.